Green, Sophie M. C. http://orcid.org/0000-0002-2622-5377
Rousseau, Nikki
Hall, Louise H.
French, David P.
Graham, Christopher D.
Lloyd, Kelly E.
Collinson, Michelle
Ow, Pei Loo
Taylor, Christopher
Howdon, Daniel
Foy, Robbie
Walwyn, Rebecca
Clark, Jane
Parbutt, Catherine
Waller, Jo
Buxton, Jacqueline
Moore, Sally J. L.
Velikova, Galina
Farrin, Amanda
Smith, Samuel G.
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR300588)
Yorkshire Cancer Research (L417)
Manchester Biomedical Research Centre (IS-BRC-1215-20007, NIHR203308)
Breast Cancer Now
Article History
Accepted: 15 July 2024
First Online: 26 July 2024
Declarations
:
: The study has been approved by Wales Research Authority Research Ethics Committee 3 (21/WA/0322) and is a registered clinical trial (ISRCTN registry, ISRCTN10487576, 16/12/2021). It is sponsored by the University of Leeds (governance-ethics@leeds.ac.uk). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants.
: GV acknowledges honoraria from Pfizer, Novartis, and Eisai; advisory board consultancy fees from AstraZeneca, Roche, Novartis, Pfizer, Seagan, Esisai, and Sanofi; and institutional grants from IQVIA and Pfizer. All other authors have no relevant conflicts of interest to disclose.